Expression and clinical significance of PD-1, PD-L1 and tumor infiltrating lymphocytes in neuroblastoma
Journal Title: Chinese Journal of Clinical Research - Year 2024, Vol 37, Issue 2
Abstract
<b>Objective</b> To investigate the expression of programmed cell death protein 1(PD-1), programmed cell death 1 ligand 1 (PD-L1) and tumor infiltrates lymphocytes (TIL) density in neuroblastoma and the relationship between them and the clinicopathological features of patients. <b>Methods</b> The postoperative tumor tissues of 58 patients with neuroblastoma who underwent surgical resection in Shanxi Children ‘s Hospital from January 2000 to June 2022 were selected, and the expression of PD-1 in tumor lymphocytes and PD-L1 in tumor cells were detected by immunohistochemical method. T lymphocyte density of CD3+, CD4+ and CD8+ was detected. The expression of PD-1 and PD-L1 and the relationship between T lymphocyte density of different subgroups and clinicopathological characteristics were analyzed. <b>Results</b> The positive expression rates of PD-1 and PD-L1 protein were 44.8% and 43.1%, respectively. There were significant differences in the expression of PD-L1 in INSS stage, INRGSS stage, pathological type and differentiation type (P<0.05). PD-1 expression was significantly different in different tumor location, INSS stage and INRGSS stage (P<0.05). PD-1 was correlated with PD-L1 expression (r=0.318, P=0.011). The density of tumor infiltrating T cells was significantly different in different INSS stage and INRGSS stage (P<0.05). The expression of CD3+T cells around the nest, CD3+T cells in the nest and CD8+T cells around the nest were correlated with the expression of PD-1 (r=0.265, 0.287, 0.309, P＜0.05.) <b>Conclusion</b> High expression of PD-L1 in neuroblastoma predicts worse prognosis, and tumor-infiltrating T lymphocytes may be involved in the regulation of PD-1 expression. Immunotherapy targeting PD-1/PD-L1 signaling pathway is expected to be a potential therapeutic target for neuroblastoma.
Authors and Affiliations
QIAO Jiahua*, HAO Ziqi, HUANG Ye, WEI Junni, LI Suhong
Keywords
Related Articles
- EP ID EP736524
- DOI 10. 13429/j.cnki.cjcr.2024.02.019
- Views 69
- Downloads 0
Effects of a single epidural injection of low-dose esketamine on perioperative sedation and analgesia during cesarean section
Objective To evaluate the analgesic and sedative effect of single epidural application of esketamine in cesarean section during perioperative period, and analyze the clinical application value of esketamine in cesarean s...
Research on the mechanism of immune escape mediated by microenvironment in multiple myeloma
Multiple myeloma (MM) is a malignant tumor of the hematological system caused by abnormal proliferation of plasma cells in bone marrow. The progression of the disease is strongly regulated by immunosuppressive tumor micr...
Progress in clinical application of esketamine in pediatric anesthesia
Ketamine is a commonly used anesthetic drug, but its clinical use declined in the late 1990s due to its postoperative nightmares, extrapyramidal syndrome, and a tendency to abuse. As an isomer of ketamine, esketamine is...
Mechanism of myocardial mitochondrial injury in sepsis
Sepsis and infectious shock remain the leading causes of death in critically ill patients. Despite the adoption of various treatment strategies to date, the outcomeshave been suboptimal. Sepsis-induced myocardial dysfunc...
Expression and clinical significance of IGFBP7 and TGFβ1 in esophageal squamous cell carcinoma
"<b>Objective</b> To investigate the expression of insulin-like growth factor binding protein 7 (IGFBP7) and transforming growth factor β1(TGFβ1) in esophageal squamous cell carcinoma (ESCC) tissues and their possible me...